Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. Juni 2019 08:00 ET | Quelle: BioSyent Inc.

BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products

TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two...
15. März 2019 12:35 ET | Quelle: BioSyent Inc.

BioSyent Schedules Q4 2018 Earnings Release for March 20, 2019

TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended December 31, 2018...
08. November 2018 09:22 ET | Quelle: BioSyent Inc.

BioSyent Schedules Q3 2018 Earnings Release for November 21, 2018

TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2018...
22. August 2018 08:00 ET | Quelle: BioSyent Inc.

BioSyent Releases Q2 and H1 2018 Results

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2018. Key...